Evolent Health
EVH
110 hedge funds and large institutions have $672M invested in Evolent Health in 2016 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 4 closing their positions.
750% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 4
150% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 18
94% more capital invested
Capital invested by funds: $347M → $672M (+$325M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
38% more funds holding
Funds holding: 80 → 110 (+30)
16.82% more ownership
Funds ownership: 42.43% → 59.24% (+17%)
4% less call options, than puts
Call options by funds: $596K | Put options by funds: $620K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$28.3M |
| 2 |
JP Morgan Chase
New York
|
+$18.8M |
| 3 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
+$17.9M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$16.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$24.7M |
| 2 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$16M |
| 3 |
PA
Perceptive Advisors
New York
|
-$10.4M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.09M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$2.87M |
EVH Hedge Fund Activity: Q3 2016 in Review
110 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2016, worth a combined $672M — up 94% from $347M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new EVH positions and 4 closed out — a net gain of 30 holders — while 45 added to existing stakes and 18 trimmed.
The largest buyer was Capital World Investors, adding an estimated $28.3M. The largest seller was Wells Fargo, cutting an estimated $24.7M.
- 110 institutional investors held Evolent Health (EVH) as of Q3 2016, up from 80 in Q2 2016.
- Funds reported $672M of Evolent Health stock for Q3 2016, up 94% quarter-over-quarter.
- 34 funds opened new Evolent Health positions in Q3 2016 and 4 closed out, a net change of +30 holders.
- The largest Evolent Health buyer in Q3 2016 was Capital World Investors, an estimated $28.3M added.
- The largest Evolent Health seller in Q3 2016 was Wells Fargo, an estimated $24.7M sold.
Based on aggregated 13F filings for Q3 2016.